Dumitru, Raluca Bianca (2019) Investigation and risk stratification of systemic sclerosis heart involvement. PhD thesis, University of Leeds.
Abstract
Primary systemic sclerosis primary heart involvement (pSSc-HI) is one of the leading causes of death in SSc. Sensitive testing suggests that the majority of patients have subclinical involvement; however, there is little understanding of its pathogenesis, dynamics and importantly, the optimal approach to clinical detection and management. Identifying the at-risk patient for more intensive monitoring and management is thus essential.
By applying sensitive tools, including implantable loop recorder (ILR) and cardiovascular magnetic resonance (CMR) the thesis proposes to provide a comprehensive assessment of pSSc-HI and to identify clinical and cardiac serum markers that could aid early identification of patient at risk of pSSc-HI. The thesis also evaluates the predictive value of subclinical CMR abnormalities for the development of cardiovascular (CV) outcomes and assesses for any interval change of CMR detected pSSc-HI and whether disease-modifying anti-rheumatic (DMARD) or vasodilator treatment can alter the course of pSSc-HI.
The thesis demonstrates significant ILR findings especially in a poor prognosis group, supporting therefore the use of ILR in SSc patients. CMR-extracellular volume (ECV), marker of diffuse fibrosis and cardiac biomarkers high-sensitivity troponin I (hs-TnI) and N-terminal pro-brain natriuretic peptide (NT-proBNP) associate with ILR abnormalities, suggesting their potential value in detecting pSSc-HI arrythmias. Three distinctive CMR findings are identified: diffuse and focal fibrosis and reduced myocardial perfusion. Skin score, digital ulcers and cardiac biomarkers are associated with CMR abnormalities, whilst CMR-ECV and NT-proBNP predict the development of future CV outcomes. Finally, no significant interval change in CMR parameters is observed, albeit a higher likelihood of CMR deterioration is noted in a poor prognosis group, whilst DMARD and vasodilator treatment do not seem to alter the course of CMR pSSc-HI.
The results of the thesis are thus providing a first step towards risk stratification of pSSc-HI, that will support future larger studies.
Metadata
Supervisors: | Buch, Maya H and Del Galdo, Francesco and Plein, Sven |
---|---|
Keywords: | systemic sclerosis, primary heart involvement, cardiovascular magnetic resonance, implantable loop recorder, risk stratification |
Awarding institution: | University of Leeds |
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Musculoskeletal Disease (Leeds) |
Identification Number/EthosID: | uk.bl.ethos.805293 |
Depositing User: | Mrs Raluca Bianca Dumitru |
Date Deposited: | 07 May 2020 06:13 |
Last Modified: | 11 May 2023 09:53 |
Open Archives Initiative ID (OAI ID): | oai:etheses.whiterose.ac.uk:26320 |
Download
Final eThesis - complete (pdf)
Filename: PhD thesis RBD_final.pdf
Licence:
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 2.5 License
Export
Statistics
You do not need to contact us to get a copy of this thesis. Please use the 'Download' link(s) above to get a copy.
You can contact us about this thesis. If you need to make a general enquiry, please see the Contact us page.